Labs Opened in Science Park


Turin - The Bracco Group, an Italian biopharmaceutical company, has recently opened a new location in the Italian region of Piedmont. The new site at the BioIndus-try Park Canavese near Turin comprises laboratories for exploratory research into new diagnostic imaging procedures. Furthermore, two pilot plants for the industrialisation of medical diagnosis contrast media production processes are planned. The Canavese Park was formed in 1988 to promote public and private-sector co-operations.
The new dual location is another important enhancement to the Bracco R&D system in Italy: this network began with the Research Centre in Milan and now includes the laboratories for new forms of drug delivery at the Science Park in Trieste, the Molecular Biology Laboratory at the San Raffaele Biomedical Science Park in Milan and the Materials Engineering Laboratory at the Technology Park in Naples.



Milan – Everyone agrees that Italy is not Greece, but it is common wisdom that the country could also be doing better. Considering the meagre growth of the Italian economy in the last decade however, data fom the 2011 survey of...



Milan – Italian drugmaker Newron Pharmaceuticals S.p.A. and Merck Serono have broadened the scope of their 5-year-old collaboration on CNS drugs. In addition to the Parkinson’s treatment safinamide, under the terms of a new...



Milan/Berlin – Swiss-Italian biotech Philogen SpA has revoked its plan to sell a 23% stake worth EUR65.3m and go public on the Milan stock exchange this Friday. The move came after German Bayer HealthCare unexpectedly terminated...



Rome – The EUR2.5m ERC Advanced Grants are the Grammies of European science – not in the same league as a Nobel Prize, but still a lucrative honor. In the fourth round since 2007, the European Research Council awarded some a590m...



Modena/London – Researchers from Germany, Italy and the UK have identified a molecule that is key to the onset of addiction and also involved into memory formation (EMBO Journal, doi:10.1038/emboj.2010.279). According to results...



Genoa/Philadelphia — The inexpensive anti-gout drug allopurinol can counteract colorectal adenoma progression, according to data presented yesterday at the 9th Annual AACR Frontiers in Cancer Prevention Research Conference...

Displaying results 11 to 20 out of 181

< Previous 11-20 Next >

© 2007-2015 BIOCOM

Product of the week



All Events

Current issue

All issues